This is not a new demonstration format. It follows our existing public case verification process. Sourced from AArete's official public case study, we isolated the later-stage results first, then reconstructed only what was knowable at decision time into an instructional data package. Minerva Advisor completed one paid live run, and this is a verified replay of an actual Decision Room session. This is an independent teaching simulation based on a public source. It does not imply that AArete used, reviewed, endorsed, sponsored, certified, or commissioned Minerva Advisor, and it does not represent real correspondence or real client results.

The case opens with a regional Medicaid managed care organization serving a large metropolitan area. Potentially preventable readmissions are high, patients are often hard to locate or engage, and the provider network is limited and nearing capacity. Root causes vary by hospital and are not yet known. Minerva is asked to weigh two paths: roll out a single solution network-wide right away, or first run a time-limited pilot at high-risk hospitals to validate root causes, patient accessibility, care transitions, and the safety of necessary care.

This run drew on one selected public source and identified four decision-relevant roles. It separated five confirmed facts from two inferences and three items still needing confirmation. It compared two paths, rollout versus pilot, and retained three alternative explanations along with one reversal condition. Together these five items form an auditable work receipt that executives can trace line by line.

Here is what was known at decision time: readmissions were elevated, patients were difficult to reach, the provider network was constrained, and existing matching tools were outdated. Here is what remained unknown: how much case mix and hospital-level variation drove readmissions, how much discharge and care management practices contributed, what social barriers were involved, and whether any future improvement would reflect real reductions or simply delayed hospitalizations and coding shifts.

The strongest challenge the system retained: readmissions may be driven mainly by case-mix differences rather than fixable processes, so a single intervention could fail regardless of the path chosen. Reported improvements could also reflect delayed hospitalization or coding changes rather than a true reduction, and network capacity strain could itself be the dominant driver rather than the intervention being tested. The reversal condition is explicit: if pilot data show consistent root causes, safe capacity, and no equity distortion across hospitals, the recommendation reverses, and the network should expand immediately rather than prolonging the pilot.

AArete's later-stage work, its data analysis, its review of care management processes, the five-hospital pilot itself, the post-discharge outreach and provider matching interventions, and the eight-month results showing reduced readmissions and spending were all held out of the decision input. The published answer was deliberately excluded so Minerva had to reason from only the decision-time facts.

Three advisors cross-check the same judgment from different angles. Marcus frames the real decision as which hospitals and patients qualify for an initial trial. Sofia models consequences for quality, member care, and the clinical network. Evelyn challenges whether a single-hospital pilot can be representative, warning that patients most in need of help are often hardest to reach, and that looking only at average results risks mistaking selection bias for success. All three converge on a time-boxed pilot with patient safety and equitable access as hard stop criteria.

The executive adds a firm condition before the pilot can proceed: it must include high-risk and hard-to-reach patients by design, results must be examined by hospital and by condition, and any delay in necessary hospitalization, any safety deterioration, or any network overload must trigger an immediate stop. This response is logged and becomes part of the decision record.

Comparing the two paths directly: immediate network-wide rollout delivers fast coverage, but it risks amplifying flawed assumptions and straining an already limited network before root causes are understood. A time-boxed pilot at high-risk hospitals first validates accessibility, care transitions, and safety, at the cost of delaying network-wide benefits. Weighing both, and testing whether the executive's added conditions change the underlying judgment, Minerva confirms the pilot path remains stronger, and the executive selects it.

The committed action: quality, member care, and clinical network teams charter the pilot with defined high-risk hospital sites, mandatory inclusion of hard-to-reach patients, and pre-set stop, expand, or reverse thresholds, brought back to the committee for approval before any network-wide rollout decision.

This run used four model calls, delivering the first decision in 18.739 seconds and completing the full result in 27.175 seconds, passing both the 30-second first-decision threshold and the 45-second complete-result threshold. The case passed ten out of ten decision-quality checks. This remains a single-case live test, not a demonstration of production-level service, and it does not represent real customer outcomes.